Replies to post #218141 on Biotech Values

[semi_infinite]

I closed out my small amount for tax loss last year. Haven't followed since. Perhaps time to look at it again.

[swampboots]

EYPT would have a drug to treat over 4 million inflammatory
patients with no competition for its lasting long term effects if PR is legit?
I will follow the financial structure by April 2nd.

[semi_infinite]

EYPT - Not sure what the sharp rise is about. Sold June 2.5 CCs on my small position.

[DewDiligence]

EYPT—(+176%)—reports phase-2 non-inferiority of AMD drug-eluting implant to (regular-dose) Eylea:

https://www.globenewswire.com/news-release/2023/12/04/2789884/0/en/EyePoint-Pharmaceuticals-Announces-Positive-Topline-Data-from-the-Phase-2-DAVIO-2-Trial-of-EYP-1901-in-Wet-AMD-Achieving-All-Primary-and-Secondary-Endpoints.html